| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |